OCULAR myasthenia distresses. The patients neither see well nor look their best because of ptosis, strabismus, and diplopia.
Agius argues that half of the patients with ocular myasthenia have electromyographic evidence of generalized neuromuscular dysfunction and that most go on to develop generalized weakness, especially in the first year. He advocates treating patients with ocular myasthenia and generalized electromyographic changes not only for symptomatic relief, but to suppress the immune response. He believes that failing to do so may set the stage for exacerbations and progression.
Hachinski V. Treatment of Ocular Myasthenia. Arch Neurol. 2000;57(5):753. doi:10.1001/archneur.57.5.753
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.